Abstract
Infrared (IR) based histopathology offers a new paradigm in looking at tissues and can provide a complimentary information source for more classical histopathology, which makes it a noteworthy tool given possible clinical application. The goal of this study is to build a robust machine learning model using IR imaging of pancreatic cancer histopathology on a single pixel level. In this article, we report a pancreatic cancer classification model based on data from over 600 biopsies (coming from 250 patients) imaged with IR diffraction-limited spatial resolution. To fully research model’s classification ability, we measured tissues in Standard and High Definition using two optical setups. This forms one of the largest IR datasets analyzed up to now, with almost 700 million spectra of different tissue types. The first classification model, based on six tissue classes, created for comprehensive histopathology achieved AUC values on the pixel (tissue) level above 0.95. We successfully developed a comprehensive histopathology digital staining model for pancreatic tissues based on biochemical information extracted from IR spectra.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Pancreatic cancer comprehensive histopathology based on IR chemical imaging project, which was carried out within the Homing programme (grant no. Homing/2016-2/20) of the Foundation for Polish Science co-financed by the European Union under the European Regional Development Fund.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was granted by Ethics committee at Jagiellonian University in Krakow (no. 1072.6120.304.2020).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos